Royal Bank Of Canada Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) had its price target lifted by stock analysts at Royal Bank Of Canada from $605.00 to $615.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an "outperform" rating on the medical equipment provider's stock. Royal Bank Of Canada's price target suggests a potential upside of 24.03% from the company's previous close.

A number of other brokerages have also issued reports on ISRG. Barclays lowered their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Citigroup reiterated a "buy" rating and issued a $650.00 price objective (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Erste Group Bank reiterated a "hold" rating on shares of Intuitive Surgical in a research report on Wednesday. BTIG Research lifted their price objective on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the company from $515.00 to $440.00 in a research report on Monday, June 9th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $592.05.

Intuitive Surgical Price Performance

Shares of ISRG traded up $7.25 during mid-day trading on Wednesday, reaching $495.86. 1,870,941 shares of the company's stock were exchanged, compared to its average volume of 1,842,693. The stock has a market capitalization of $177.73 billion, a PE ratio of 69.16, a price-to-earnings-growth ratio of 5.45 and a beta of 1.64. The business's fifty day simple moving average is $529.86 and its 200-day simple moving average is $535.13. Intuitive Surgical has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same period last year, the firm posted $1.78 earnings per share. Equities research analysts predict that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. The trade was a 19.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director owned 6,371 shares of the company's stock, valued at $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,798 shares of company stock worth $3,955,331 over the last 90 days. Corporate insiders own 0.70% of the company's stock.

Institutional Trading of Intuitive Surgical

A number of institutional investors have recently modified their holdings of the company. AlphaCore Capital LLC lifted its position in Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after acquiring an additional 18 shares in the last quarter. Accredited Investors Inc. lifted its position in Intuitive Surgical by 1.9% during the 4th quarter. Accredited Investors Inc. now owns 1,040 shares of the medical equipment provider's stock worth $543,000 after acquiring an additional 19 shares in the last quarter. Second Line Capital LLC lifted its position in Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after acquiring an additional 19 shares in the last quarter. Aaron Wealth Advisors LLC lifted its position in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock worth $1,374,000 after acquiring an additional 19 shares in the last quarter. Finally, Colonial Trust Co SC lifted its position in Intuitive Surgical by 8.8% during the 4th quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider's stock worth $128,000 after acquiring an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.